If everything looks good, well move forward with a prescription that fits your situation
In the scientific literature, the molecule is described as a single peptide with a multi-receptor profile of action, designed to simultaneously modulate several key metabolic axes
These peptides are not weight-loss medications and shouldnt be compared to GLP-1 drugs like semaglutide or tirzepatide
In pharmaceutical options, two names that frequently emerge are Semaglutide (Ozempic and Weygovy) and Trizepitide (Mounjaro or Zepbound)
This theoretical synergy has not been studied in any published, peer-reviewed clinical trial, and there is no evidence base supporting the combined use of these two compounds in humans
Amer Academy Dermat Meeting, February 2002, Abstract P68, P69 Leyden J., Stephens T., Finkey M., Barkovic S